INSMED Inc — Director's Dealing 2020

May 15, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2020-05-12

Reporting Person: Bonstein Sara (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-05-12	Stock Option (right to buy)	$24.70	A	34890	Acquired	2030-05-12	Common Stock (34890)	Direct

Footnotes

F1: The option becomes exercisable based on the following vesting schedule: twenty-five percent (25%) vests on the first anniversary of the date of grant and twelve and one-half percent (12.5%) vests on each six-month anniversary date thereafter through the fourth anniversary of the date of grant, subject to Ms. Bonstein's continued employment with the Company on each vesting date.